CashuExelixis Advances Cancer Treatment: STELLAR-303 Trial Results Impress Amid Bayer AG Market Trends21 days ago
CashuExelixis' Zanzalintinib Shows Promise in Phase 3 RCC Trial Amid Bayer AG Stock Fluctuations23 days ago